Back to Search
MICHAEL GELFAND, M.D.
M.D.
Nuclear Medicine Physician
NPI: 1114933538Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.
PMID 19083225·Pediatr Radiol·2009
6-review
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.
PMID 19349386·Chest·2009
8-other
Ventilation-perfusion scintigraphy in children and adolescents is associated with a low rate of indeterminate studies.
PMID 18716508·Clin Nucl Med·2008
8-other
PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager.
PMID 17707244·Semin Nucl Med·2007
6-review
Q&A: perspective on pediatric nuclear medicine: an interview with Michael J. Gelfand.
PMID 16673553·J Nucl Med·2006
8-other
Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients.
PMID 15988582·Pediatr Radiol·2005
8-other
123I-MIBG uptake in the neck and shoulders of a neuroblastoma patient: damage to sympathetic innervation blocks uptake in brown adipose tissue.
PMID 15205842·Pediatr Radiol·2004
5-case
Urinary tract infection. American College of Radiology. ACR Appropriateness Criteria.
PMID 11037509·Radiology·2000
4-observational
The initial renal ultrasound examination in children with urinary tract infection: the prevalence of dilated uropathy has decreased.
PMID 11075596·Pediatr Radiol·2000
4-observational
Vesicoureteral reflux: subpopulations of patients defined by clinical variables.
PMID 10663525·Pediatr Radiol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVE, ML 5031
CINCINNATI, OH 45229 - Phone
- (513) 636-4251
Quick Facts
- NPI
- 1114933538
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile